Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo, Daiichi Sankyo Group is involved in the research, development, manufacturing, and marketing of pharmaceuticals. They are based in Tokyo, Japan.
View Top Employees from Daiichi Sankyo IncWebsite | http://www.daiichisankyo.com |
Revenue | $9.27 billion |
Employees | 102 (59 on RocketReach) |
Address | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Tokyo, JP |
Phone | +81 3-6225-1111 |
Technologies |
JavaScript,
HTML,
ASP.NET
+24 more
(view full list)
|
Industry | Information Technology and Services, Pharmaceuticals, Healthcare |
Keywords | Pharmaceutical Research, Drug Development And Manufacturing, Pharmaceuticals Logistics, Healthcare Products, Biopharmaceuticals, Pharmaceutical Marketing, Pharmaceutical Development, Biotechnology, Pharmaceutical Products |
Competitors | Aurobindo Pharma, Dr Reddy's NZ Ltd, Eisai Inactive Page, Lek Pharmaceuticals d.d., Merz Therapeutics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 6215 Companies, NAICS Code 62151 Companies, NAICS Code 42 Companies, NAICS Code 621 Companies, NAICS Code 4242 Companies, NAICS Code 42421 Companies, NAICS Code 424 Companies, NAICS Code 62 Companies |
Looking for a particular Daiichi Sankyo Inc employee's phone or email?
The Daiichi Sankyo Inc annual revenue was $9.27 billion in 2024.
Chuke Nwachuku is the Senior Director, Clinical Development of Daiichi Sankyo Inc.
59 people are employed at Daiichi Sankyo Inc.
Daiichi Sankyo Inc is based in Tokyo, Tokyo.
The NAICS codes for Daiichi Sankyo Inc are [6215, 62151, 42, 621, 4242, 42421, 424, 62].
The SIC codes for Daiichi Sankyo Inc are [28, 283].